To evaluate the association between TAPSE/sPAP ratio and CKD stage severity and assess age-related effect modification.<h4>Methods</h4>This cross-sectional study enrolled 120 participants: 40 patients with stage I-II CKD, 40 with stage III-IV CKD, and 40 healthy controls. Here, PDZK1IP1 is linked to chronic kidney disease.